(Q41040058)

English

Topographical distribution of [125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection

scientific article published on April 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Topographical distribution of [125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Paul A. Lapchak

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

author name string

Araujo DM

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Hilt DC

3

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Jiao S

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Collin F

5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Miyoshi Y

6

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Yi A

7

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Zhang Z

8

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Gash DM

9

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 1998

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

789

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

9-22

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Glial cell line-derived neurotrophic factor induces the dopaminergic and cholinergic phenotype and increases locomotor activity in aged Fischer 344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Glial cell line-derived neurotrophic factor: distribution and pharmacology in the rat following a bolus intraventricular injection

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

[3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901495-9

7 January 2021

Identifiers

10.1016/S0006-8993(97)01495-9

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41040058&oldid=2093389942"